nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Add-on therapy for hypercholesterolemia: a pilot comparison of two gastrointestinally-acting agents in statin-treated patients
|
Zema, Michael James |
|
2009 |
3 |
2 |
p. 119-124 6 p. |
artikel |
2 |
A patient with new-onset hypercholesterolemia
|
Liberopoulos, Evangelos N. |
|
2009 |
3 |
2 |
p. 143-145 3 p. |
artikel |
3 |
Benefits of the MEDPED treatment support program for patients with familial hypercholesterolemia
|
Stephenson, Susan Huckendubler |
|
2009 |
3 |
2 |
p. 94-100 7 p. |
artikel |
4 |
Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study
|
Insull Jr., William |
|
2009 |
3 |
2 |
p. 109-118 10 p. |
artikel |
5 |
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies
|
Jones, Peter H. |
|
2009 |
3 |
2 |
p. 125-137 13 p. |
artikel |
6 |
Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis
|
Alsheikh-Ali, Alawi A. |
|
2009 |
3 |
2 |
p. 138-142 5 p. |
artikel |
7 |
Flushing and other dermatologic adverse events associated with extended-release niacin therapy
|
Guyton, John R. |
|
2009 |
3 |
2 |
p. 101-108 8 p. |
artikel |
8 |
From the Editor
|
Brown, W. Virgil |
|
2009 |
3 |
2 |
p. 61-62 2 p. |
artikel |
9 |
Is HDL function as important as HDL quantity in the coronary artery disease risk assessment?
|
Dodani, Sunita |
|
2009 |
3 |
2 |
p. 70-77 8 p. |
artikel |
10 |
Letter to the Editor
|
Trenkle, Douglas |
|
2009 |
3 |
2 |
p. 149- 1 p. |
artikel |
11 |
News from the NLA
|
|
|
2009 |
3 |
2 |
p. 63-64 2 p. |
artikel |
12 |
Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity
|
Su, Jenny W. |
|
2009 |
3 |
2 |
p. 78-84 7 p. |
artikel |
13 |
Reply
|
Shimshi, Mona |
|
2009 |
3 |
2 |
p. 149- 1 p. |
artikel |
14 |
The first recorded heterozygote for familial hypercholesterolemia
|
Durrington, Paul N. |
|
2009 |
3 |
2 |
p. 146-148 3 p. |
artikel |
15 |
The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review
|
Reddy, Kota J. |
|
2009 |
3 |
2 |
p. 85-93 9 p. |
artikel |
16 |
The use of niacin †
|
Brown, W. Virgil |
|
2009 |
3 |
2 |
p. 65-69 5 p. |
artikel |